Systematic review explores the role of RNA methylation in autoimmune rheumatic diseases

This systematic review investigates the role of RNA methylation in the pathogenesis of autoimmune rheumatic diseases (ARDs). The scope of the review covers several conditions, including rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, primary Sjögren’s syndrome, and systemic sclerosis.

The authors synthesize evidence indicating that RNA methylation serves as a key epitranscriptomic modification. This process regulates gene expression by influencing critical mechanisms such as stability, splicing, nuclear translocation, and degradation. The review highlights that these modifications affect essential biologic processes, specifically inflammation and the immune response.

While the review notes that RNA modification plays a role in the pathogenesis and progression of ARDs, the specific clinical implications remain an area for ongoing study. The authors suggest that understanding these mechanisms of RNA modification may eventually lead to the development of novel diagnostic biomarkers and therapeutic strategies.

Limitations regarding specific study populations, sample sizes, and follow-up durations were not reported in the provided data. Clinicians should view these findings as foundational biological insights that necessitate further validation in clinical settings.